About this iReport
  • Not verified by CNN

  • Click to view vaniel's profile
    Posted June 21, 2014 by

    More from vaniel

    Clinical-stage biotechnology company

    Founded in 2006, Avalanche Biotechnologies, Inc., is a privately held, clinical-stage biotechnology company that develops technologies and products for sustained delivery of therapeutic proteins. Avalanche's lead product, AVA-101, is currently under development in a Phase 2a trial for wet age-related macular degeneration. Avalanche's BioFactoryTM platform technology is a proprietary adeno-associated virus (AAV)-based gene therapy discovery and development technology optimized for ophthalmology that utilizes a directed evolution approach to generate novel drug candidates. The company is headquartered in Menlo Park, California.

    For more information, please visit www.avalanchebiotech.com.
    Add your Story Add your Story